PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME

被引:63
|
作者
BURNS, ER
GOLDBERG, SN
WENZ, B
机构
[1] Department of Laboratory Medicine, Albert Einstein College of Medicine, Bronx, NY 10461
关键词
HEMOSTASIS; COAGULATION; PROTHROMBIN TIME; ACTIVATED PARTIAL THROMBOPLASTIN TIME;
D O I
10.1093/ajcp/100.2.94
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Single coagulation factor deficiencies predictably prolong the prothrombin time (PT) and activated partial thromboplastin time (APTT) at levels below 35% of normal activity. Acquired coagulopathies generally are characterized by multiple coagulation factor deficiencies. The effect was studied of such combined deficiencies on the PT/APTT using plasma from patients congenitally deficient in specific factors and pooled normal plasma. The PT begins to lengthen when individual factor levels fall below 25%. The APTT becomes prolonged when the levels of Factor V fall below 45%; the levels of Factors II and XI fall below 40%; and the levels of Factors I, V, VII, VIII, IX, and XII fall below 25% of normal. When plasma samples containing 50% activity of a single factor and 100% of all other factors were prepared by mixing the congenitally deficient plasma samples with the normal pool, the resulting mixtures had normal PT and APTT values. However, when two of these 50% factor-deficient plasmas were combined so that the mixture contained 75% activity of two coagulation factors and 100% of all other factors, the resulting PT and APTT were prolonged over the clotting times of either 50% factor-deficient plasma. Similar findings were obtained in patients with mild factor reductions caused by warfarin treatment. These data indicate that prolongations of the PF and APTT in disorders of coagulation affecting multiple factors represent less of a reduction in factor levels than is generally appreciated. This may explain the poor clinical correlation between abnormalities in these test results and clinical bleeding in acquired disorders of hemostasis.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 50 条
  • [1] SENSITIVITY OF 3 ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS TO COAGULATION-FACTOR DEFICIENCIES
    TURI, DC
    PEERSCHKE, EI
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 85 (01) : 43 - 49
  • [2] Effect of Hemopure(R) on prothrombin time and activated partial thromboplastin time on seven coagulation analyzers
    Moreira, PL
    Lansden, CC
    Clark, TL
    Gawryl, MS
    CLINICAL CHEMISTRY, 1997, 43 (09) : 1792 - 1792
  • [3] The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
    Samara, Evangelia
    Stamatiou, Konstantinos
    Balanika, Marina
    Tzimas, Petros
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [4] EVALUATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS IN DETECTION OF BLOOD-COAGULATION FACTOR DEFICIENCIES
    COMPTON, JL
    RODMAN, NF
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1033 - 1033
  • [5] In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies
    Toulon, P.
    Eloit, Y.
    Smahi, M.
    Sigaud, C.
    Jambou, D.
    Fischer, F.
    Appert-Flory, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (04) : 389 - 396
  • [6] The effects of apixaban on routine coagulation tests including prothrombin time and activated partial thromboplastin time
    Lowe, A.
    Hickey, K.
    Maclean, R.
    van Veen, J.
    Kitchen, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 21 - 21
  • [7] DIAGNOSTIC USES OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME AND PROTHROMBIN TIME
    SUCHMAN, AL
    GRINER, PF
    ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) : 810 - 816
  • [8] Efficacy of prothrombin time and activated partial thromboplastin time as a gauge for specific factor inhibition
    Keller, C.
    Dennis, J.
    Monroe, D.
    Tidwell, R.
    Church, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 906 - 907
  • [9] FAMILIAL MULTIPLE COAGULATION-FACTOR DEFICIENCIES
    SOFF, GA
    LEVIN, J
    BELL, WR
    CLINICAL RESEARCH, 1981, 29 (05): : A864 - A864
  • [10] Effect of Pre-analytical Conditions on Prothrombin Time and Partial Activated Thromboplastin Time
    Beatriz, Moutinho
    Beatriz, Pinto
    Rita, Cardoso
    Helena, Alves
    Monica, Botelho
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (04) : 327 - 331